These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10653157)

  • 21. Frequency analysis of recipient-reactive helper and cytotoxic T lymphocyte precursors using a combined single limiting dilution assay.
    Wang XN; Proctor SJ; Dickinson AM
    Transpl Immunol; 1996 Sep; 4(3):247-51. PubMed ID: 8893457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation.
    Kircher B; Niederwieser D; Gächter A; Lindner B; Mitterschiffthaler A; Urban C; Greinix H; Peters C; Lätzer K; Gastl G; Nachbaur D
    Int J Lab Hematol; 2008 Dec; 30(6):499-507. PubMed ID: 18522713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The helper T lymphocyte precursor (HTLp) frequency does not predict outcome after HLA-identical sibling donor G-CSF-mobilised peripheral blood stem cell transplantation.
    Healey G; Schwarer AP
    Bone Marrow Transplant; 2002 Sep; 30(6):341-6. PubMed ID: 12235517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential immunogenicity of HLA class I alloantigens for the humoral versus the cellular immune response: "towards tailor-made HLA mismatching".
    Claas FH; Roelen DL; Mulder A; Doxiadis II; Oudshoorn M; Heemskerk M
    Hum Immunol; 2006 Jun; 67(6):424-9. PubMed ID: 16728264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single [3H]thymidine-based limiting dilution analysis to determine HTLp and CTLp frequencies for bone marrow donor selection.
    van der Meer A; Joosten I; Ruiter J; Allebes WA
    Bone Marrow Transplant; 1997 Jul; 20(2):149-55. PubMed ID: 9244419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimisation of the CT h4S bioassay for detection of human interleukin-4 secreted by mononuclear cells stimulated by phytohaemaglutinin or by human leukocyte antigen mismatched mixed lymphocyte culture.
    Petersen SL; Russell CA; Bendtzen K; Vindeløv LL
    Immunol Lett; 2002 Oct; 84(1):29-39. PubMed ID: 12161281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enumeration of human alloreactive helper T lymphocyte precursor frequencies by limiting dilution analysis of interleukin-2 production.
    Young NT; Roelen DL; Dallman MJ; Wood KJ; Morris PJ; Welsh KI
    J Immunol Methods; 1996 Sep; 195(1-2):33-41. PubMed ID: 8814317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
    Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
    Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alloreactive helper T cell responses in kidney transplant patients].
    Weng L; Lin C; Mason P; Lechler R; Gao X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):505-7. PubMed ID: 12903390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesis.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(3A):1871-88. PubMed ID: 10928121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
    Warrino DE; Olson WC; Knapp WT; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Edwards RP; Kast WM; Storkus WJ
    Clin Cancer Res; 2004 May; 10(10):3301-8. PubMed ID: 15161683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quantitative assessment of allospecific interleukin-2-secreting helper T lymphocyte in cord blood with limiting dilution assay].
    Jian Q; Xie Y; Xie H
    Zhonghua Xue Ye Xue Za Zhi; 1997 Nov; 18(11):588-91. PubMed ID: 15625898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A convenient and reliable IL-2 bioassay using frozen CTLL-2 to improve the detection of helper T lymphocyte precursors.
    Weston L; Geczy A; Farrell C
    Immunol Cell Biol; 1998 Apr; 76(2):190-2. PubMed ID: 9619491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered promiscuous T helper peptides for the induction of immune responses.
    Ruiz M; Llopiz D; Zabaleta A; Lasarte JJ; Borrás-Cuesta F; Sarobe P
    Mol Immunol; 2007 Mar; 44(9):2205-12. PubMed ID: 17157914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of HLA molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era.
    Thorsby E; Pfeffer P; Leivestad T
    Transplant Proc; 2004 Mar; 36(2 Suppl):16S-21S. PubMed ID: 15041301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.
    Angoulvant D; Clerc A; Benchalal S; Galambrun C; Farre A; Bertrand Y; Eljaafari A
    Biorheology; 2004; 41(3-4):469-76. PubMed ID: 15299278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.